Revance Therapeutics Inc. (RVNC) Dividend History

Revance Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.

Last update 10/24/2020


Dividend Yield Summary

  2015 2016 2017 2018 2019 2020
Dividends - - - - - -
Average Price 27.13 17.29 23.96 27.84 14.39 22.50
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2020 are year-to-date.

Dividend History

No history of dividends
Date Amount Per Share Note